What Allermi does

Allermi is a San Francisco-based direct-to-consumer telehealth company that delivers customized prescription nasal sprays for allergy and related nasal conditions. Patients complete an online symptom questionnaire, are evaluated by a licensed allergist (drawn from Stanford Medicine, UCLA, Weill Cornell, Johns Hopkins, and Northwestern), and receive a custom-compounded multi-ingredient spray shipped from partner pharmacies (Chemistry Rx Holdings LLC and ClearMedix Pharmacy LLC). The core product, branded Super Spray, combines up to four FDA-approved active ingredients (Azelastine, Ipratropium, Triamcinolone, Oxymetazoline) at individualized percentages under a patent-pending custom prescribing system; a companion Salinity Spray (saline mist) is bundled as the Custom Rx Nasal Spray Kit.

The company's value proposition targets chronic allergy sufferers who have failed one-size-fits-all OTC medications (Flonase, Afrin, Zyrtec), with a specific emphasis on CPAP users for whom nasal congestion is the leading cause of therapy failure, in partnership with cpap.com. All clinical services are delivered through affiliated medical professional corporations (Allermi Medical Associates, P.C., Allermi California PC, and Allermi Primary Medical Corporation). The company reports over 100,000 patients treated, 14,000-16,444 verified reviews averaging 4.7/5, and 90%+ patient-reported superior relief versus prior solutions.

Allermi operates a cash-pay subscription model that does not accept insurance but is HSA/FSA eligible. The Custom Rx Nasal Spray Kit is priced at $95 monthly (promotional $45 first month), comprising Super Spray ($60), Salinity Spray ($10), and online allergist consultation ($25). Go-to-market is entirely direct through the owned e-commerce site (www.allermi.com), supported by content/SEO (pollen tracker, educational blog), organic social, earned media coverage in major outlets (Axios, Healthline, USA Today, Yahoo), and the cpap.com referral channel. Cumulative disclosed funding is approximately $4.75 million across pre-seed (Sept 2022, $1.25M from Lucas Venture Group), seed (March 2023, $3.5M from Nelstone Ventures), and a 2024 undisclosed round (Evolution VC Partners). The company is private, headquartered in San Francisco, with 11-50 employees.

Name

Allermi

Legal name

Allermi, Inc.

Website

https://allermi.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

11–50 employees

Short description

Allermi is a San Francisco-based telehealth company that delivers custom-compounded, multi-ingredient prescription nasal sprays prescribed by Stanford-affiliated allergists directly to allergy sufferers and CPAP users across the United States on a cash-pay subscription basis.

Ownership category

akta.pro rank

Product category

Personalized Allergy Treatment (Compounded Prescription Nasal Sprays)

NAICS

Other Ambulatory Health Care Services (6219)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Allergy & Immunology Clinics (HLAKAAAA)

akta.pro secondary industries

Pulmonology & Allergy Specialty Pharmaceuticals (HLAIACAF), Respiratory & Allergy Pharmaceuticals (HLAIAAAH)

Keywords

• Custom prescription allergy treatment
• Telehealth allergy care
• Compounded nasal spray
• Multi-ingredient prescription spray
• Direct-to-consumer allergy medications

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Custom Prescription Nasal Spray Kit (Subscription): Allermi sells a Custom Rx Nasal Spray Kit consisting of Super Spray (custom prescription nasal spray), Salinity Spray (saline mist), and access to a medical care team. The primary product is the Super Spray, which is a subscription-based prescription medication. Patients receive ongoing prescription refills through a subscription model. The kit is priced at $95 (with a promotional offer of $45 for first month). Super Spray alone is $60 ($45 promotional). Online allergist consultation is $25. Salinity Spray is $10 (free with promotional offer). Treatment is HSA/FSA eligible.
2. Online Allergist Consultation: Patients pay a one-time or periodic consultation fee for an online evaluation by a licensed allergist, which results in a personalized prescription. New patient consultations are included in the kit price; formula change consults are also available.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

Core offering

Allermi is a direct-to-consumer telehealth platform that delivers custom-compounded prescription allergy nasal sprays to patients. Patients complete an online symptom consultation, are evaluated by a licensed allergist, and receive a personalized prescription nasal spray combining up to four FDA-approved active ingredients (Azelastine, Ipratropium, Triamcinolone, Oxymetazoline) tailored to their individual symptom profile. The spray is compounded by partner pharmacies and shipped directly to the patient's door on a subscription basis.

Product overview

Allermi offers a personalized medicine platform centered on a custom multi-ingredient nasal spray treatment for allergies. The core product is the Super Spray - a prescription nasal spray that combines up to four FDA-approved active ingredients (Azelastine, Ipratropium, Triamcinolone, and Oxymetazoline) into one customized formula, prescribed by allergists based on individual patient symptom profiles. This is bundled with the Salinity Spray (a moisturizing saline nasal mist) in a Custom Allergy Kit that also includes an online allergist consultation and unlimited access to the medical care team. The platform operates through telehealth consultations where patients complete a questionnaire, receive a personalized prescription, and have ongoing formula adjustment capabilities through the care team.

Differentiator

Problem solved

Functional benefit

Brands

• Super Spray: Custom prescription nasal spray formulated with up to 4 active ingredients for personalized allergy relief
• Salinity Spray

Products and services

• Super Spray (Custom Rx Nasal Spray) A prescription nasal spray that combines up to four FDA-approved active ingredients (Azelastine, Ipratropium, Triamcinolone, Oxymetazoline) into one customized formula for personalized allergy relief. Addresses sneezing, itching, congestion, runny nose, and post-nasal drip based on individual patient symptom profile.
• Salinity Spray (Saline Nasal Mist) A moisturizing saline nasal mist designed to hydrate and soothe nasal passages, helping the Super Spray work more effectively.
• Custom Rx Nasal Spray Kit Comprehensive allergy care package including Super Spray (Custom Rx Spray), Salinity Spray, online allergist consultation, and ongoing access to the medical care team, delivered to the patient's door on a subscription basis.
• Online Allergist Consultation Remote telehealth consultation with licensed allergists (from Stanford, UCLA, Weill Cornell, Johns Hopkins, Northwestern) who evaluate patient symptoms and medical history to prescribe appropriate customized nasal spray formulas.

Quantifiable outcome

• Over 90% of Allermi patients experienced superior relief vs. previous solutions; 90% experienced nearly-complete or fully-complete relief from nasal symptoms
• +6 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core.

• cpap.comcoreStrategic or Co-development Partnercpap.com (2.3M+ CPAP users) officially partnered with Allermi as its nasal congestion partner. Nasal congestion is cited as the top reason CPAP therapy fails. Allermi's prescription spray clears the airway to enable effective CPAP therapy. cpap.com vetted dozens of partners before selecting Allermi. The companies co-host educational webinars featuring sleep and allergy doctors, and cpap.com refers users to Allermi for congestion relief.
• Chemistry Rx Holdings LLCcoreTechnology or IntegrationOne of the two partner pharmacies that fulfills Allermi prescriptions. Chemistry Rx Holdings LLC compounds and ships the custom multi-ingredient nasal spray directly to patients under Allermi's telehealth model.
• ClearMedix Pharmacy LLCcoreTechnology or IntegrationOne of the two partner pharmacies that fulfills Allermi prescriptions. ClearMedix Pharmacy LLC compounds and ships the custom multi-ingredient nasal spray directly to patients under Allermi's telehealth model.
• Allermi Medical Associates, P.C.coreTechnology or IntegrationThe affiliated medical practice providing all clinical services including telehealth consultations, prescription evaluation, and ongoing care under the Allermi brand. Also includes Allermi California PC and Allermi Primary Medical Corporation in certain states. Licensed allergists from Stanford, UCLA, Weill Cornell, Johns Hopkins, and Northwestern provide care.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Curex: Curex offers custom allergy immunotherapy (sublingual drops) prescribed online via telehealth, directly overlapping with Allermi's model of personalized prescription allergy treatment delivered DTC. Both target OTC-failure allergy sufferers with subscription-based custom formulations.
• Cleared (formerly AllergEase): Cleared provides custom allergy treatment through online consultation with allergists, positioning as a personalized telehealth alternative to OTC allergy meds — the same core value proposition and customer base as Allermi.
• Hims & Hers Health: Hims & Hers is the most scaled DTC telehealth subscription platform selling prescription and OTC products directly to consumers online, including allergy and nasal offerings. Allermi operates the same GTM motion at a smaller scale and in a narrower vertical.
• Ro: Ro runs a vertically integrated telehealth pharmacy operating across multiple conditions with custom prescription products shipped directly to consumers, mirroring Allermi's D2C telehealth-plus-compounding model.
• Nurx: Nurx is a DTC telehealth provider offering custom prescription products (notably in women's health) shipped to patients after online consultation. Same subscription-driven, telehealth-plus-mail-order prescription model.
• Curology: Curology offers custom-compounded prescription skincare formulated online by clinicians and shipped via subscription. Closely parallels Allermi's custom-Rx-in-one-bottle-plus-subscription approach in a different therapeutic area.
• Thirty Madison (Keeps / Cove / Picnic): Thirty Madison operates a portfolio of specialty telehealth subscription brands (hair loss, migraine, allergies) selling custom prescription products DTC, structurally identical to Allermi's niche strategy at greater scale.

Broad incumbents

• Teladoc Health: Teladoc is the largest U.S. telehealth incumbent providing physician consultations across many specialties including allergy; broader and less specialized but exercises the same core channel Allermi leverages.
• GoodRx: GoodRx combines telehealth consultations with prescription fulfillment and OTC pharmacy e-commerce at massive scale, including allergy medications. Comparable business model with broader portfolio and lower customization.
• MDLive / Amwell: Amwell provides enterprise telehealth infrastructure and direct-to-consumer virtual visits covering allergy and primary care; serves as a broad incumbent in the online physician visit channel Allermi depends on.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/getallermi
• Instagraminstagram.com/getallermi/?hl=en
• LinkedInlinkedin.com/company/allermi

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries3 records

Funding overview

Funding rounds3 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Allermi